Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafne Capelusnik

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Seminars in Arthritis and Rheumatism|June 6, 2022
How is early spondyloarthritis defined in the literature? Results from a systematic reviewDiego Benavent, Dafne Capelusnik, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|March 26, 2026
Coping with rheumatic stressors in longstanding axial spondyloarthritis: association with patient and disease characteristicsMarc van Essen, Dafne Capelusnik, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|February 10, 2026
Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDsCasper Webers, Augusta Ortolan, Elena Nikiphorou, et al.
RMD Open|June 29, 2026
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature reviewDafne Capelusnik, Clementina López-Medina, Casper Weber, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 1, 2020
Depression Is a Major Determinant of Functional Capacity in Rheumatoid ArthritisCarolina A Isnardi, Dafne Capelusnik, Emilce Edith Schneeberger, et al.
Clinical Rheumatology|May 21, 2020
A useful tool to assess quality of LIFE in rheumatoid arthritis patients that does not require a license: QOL-RA IICarolina Ayelen Isnardi, Emilce Edith Schneeberger, Dafne Capelusnik, et al.
Clinical Rheumatology|June 23, 2021
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of RheumatologyGraciela N Gómez, Nicolás Pérez, Andrea Braillard Poccard, et al.
Lupus|October 8, 2020
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in ArgentinaLucila Garcia, Maria S Velloso, Maria V Martire, et al.
Annals of the Rheumatic Diseases|June 15, 2023
ASAS consensus definition of early axial spondyloarthritisVictoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Seminars in Arthritis and Rheumatism|June 6, 2022
How is early spondyloarthritis defined in the literature? Results from a systematic reviewDiego Benavent, Dafne Capelusnik, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|March 26, 2026
Coping with rheumatic stressors in longstanding axial spondyloarthritis: association with patient and disease characteristicsMarc van Essen, Dafne Capelusnik, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|February 10, 2026
Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDsCasper Webers, Augusta Ortolan, Elena Nikiphorou, et al.
RMD Open|June 29, 2026
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature reviewDafne Capelusnik, Clementina López-Medina, Casper Weber, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 1, 2020
Depression Is a Major Determinant of Functional Capacity in Rheumatoid ArthritisCarolina A Isnardi, Dafne Capelusnik, Emilce Edith Schneeberger, et al.
Clinical Rheumatology|May 21, 2020
A useful tool to assess quality of LIFE in rheumatoid arthritis patients that does not require a license: QOL-RA IICarolina Ayelen Isnardi, Emilce Edith Schneeberger, Dafne Capelusnik, et al.
Clinical Rheumatology|June 23, 2021
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of RheumatologyGraciela N Gómez, Nicolás Pérez, Andrea Braillard Poccard, et al.
Lupus|October 8, 2020
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in ArgentinaLucila Garcia, Maria S Velloso, Maria V Martire, et al.
Annals of the Rheumatic Diseases|June 15, 2023
ASAS consensus definition of early axial spondyloarthritisVictoria Navarro-Compán, Diego Benavent, Dafne Capelusnik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 22, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter StudyTali Eviatar, Dafne Capelusnik, Corrado Campochiaro, et al.
Pageof 4